ArticleMicrobial cell factories2026
Endophytic fungi-assisted biological synthesis of zinc oxide nanoparticles using gamma-rays for promising antibacterial and antibiofilm potential against some gram-positive bacteria.
Article in Microbial cell factories, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionEndophytic fungi of medicinal plants have gained recognition as probable sources of bioactive metabolites. In this study, sixteen endophytic fungi were isolated from basil (Ocimum basilicum) and screened for antibacterial activity using the agar well diffusion method. The most potent isolate was molecularly identified as Aspergillus tamarii (A. tamarii) by the ITS rDNA sequencing method, and the sequence was submitted to GenBank (accession no. PX474848.1). Then the strain was cultivated in different media to reduce production costs and enhance antibacterial metabolite production, including potato peel and Portulaca oleracea (P. oleracea) as low-cost alternatives to potato extract. The P. oleracea-based medium showed the highest antibacterial activity, with inhibition zones of 20.0 mm against Bacillus subtilis (B. subtilis) and 23.0 mm against Staphylococcus aureus (S. aureus). For the green synthesis of zinc oxide nanoparticles (ZnO NPs), the fungal extract was mixed with an equal volume of 1.0 mM zinc nitrate hexahydrate and exposed to gamma irradiation (20 kGy). Characterization by UV–Vis. spectroscopy, DLS, XRD, SEM, and HRTEM confirmed the formation of ZnO NPs. The synthesized nanoparticles exhibited spherical and rod-shaped morphology and an average size of 70.34 nm. Antibacterial activity was evaluated using the agar well diffusion assay and the broth microdilution method for MIC determination. The biosynthesized ZnO NPs showed inhibition zones of 26.0 ± 0.30 mm against B. subtilis and 27.0 ± 0.13 mm against S. aureus, with MIC values of 31.25 µg/mL. Antibiofilm activity, assessed by the crystal violet tube method, showed inhibition rates of 50.32 and 55.33% against B. subtilis and S. aureus, respectively, while protein leakage analysis using the Bradford assay indicated increased membrane permeability in treated bacterial cells. Overall, the bioactive metabolites and the biosynthesized ZnO NPs showed promising antibacterial and antibiofilm activities, possibly linked to increased membrane permeability, suggesting their potential use in food and medical applications.
aimThe objective of this study was to create a green synthesis of ZnO NPs using bioactive chemicals produced from endophytic fungi and gamma irradiation, as well as a cost-effective approach for producing bioactive metabolites from these fungi. IMPACT STATEMENT: The current study presents a cost-effective and environmentally friendly process for producing bioactive metabolites from endophytic fungi and biosynthesizing ZnO NPs using gamma irradiation and endophytic fungal bioactive metabolites. The biosynthesized ZnO NPs present viable substitutes for traditional antibacterial agents, especially in food and medicinal applications that target gram-positive bacteria that are resistant to drugs.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.